Ordering Recommendation

Optimize drug therapy and monitor patient adherence.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Timing of specimen collection: Predose (trough) draw at steady state concentration.

Collect

Plain red. Also acceptable: Dark green (sodium or lithium heparin), lavender (K2 or K3EDTA) or pink (K2EDTA).

Specimen Preparation

Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP standard transport tube. (Min: 0.2 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).

Remarks
Stability

After separation from cells: Ambient: 48 Hours; Refrigerated: 1 week; Frozen: 1 month
3 freeze/thaw cycles

Methodology

Quantitative Enzyme Immunoassay (EIA)

Performed

Sun-Sat

Reported

1-2 days

Reference Interval

Test Number
Components
Reference Interval
  Gabapentin, Ser/Pla
Therapeutic Range Toxic Range
2.0-20.0 ug/mL >=25.0 ug/mL

Interpretive Data

Pharmacokinetics of gabapentin vary widely among patients, particularly those with compromised renal function. Adverse effects may include somnolence, dizziness, ataxia, and fatigue.

Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

80171

Components

Component Test Code* Component Chart Name LOINC
3017898 Gabapentin, Ser/Pla 9738-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Gabapentin, Free
  • Gabarone
  • Neurontin
Gabapentin, Serum or Plasma